Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 3Recruiting 1

Sponsor Class

NETWORK 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Prostatic Neoplasms 24Breast Neoplasms 4Neoplasm Metastasis 2Prostate Adenocarcinoma 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Fulvestrant 125Trastuzumab 114Paclitaxel 113Letrozole 108pembrolizumab 79pertuzumab 75palbociclib 75Capecitabine 72Anastrozole 72Cyclophosphamide 70Carboplatin 67abemaciclib 64exemestane 63Tamoxifen 63ribociclib 60trastuzumab deruxtecan 57Surveys and Questionnaires 51Specimen Handling 50Radiotherapy 49Docetaxel 49Magnetic Resonance Spectroscopy 48Blood Specimen Collection 40olaparib 39Standard of Care 36Biopsy 33sacituzumab govitecan 31130-nm albumin-bound paclitaxel 31Doxorubicin 30Exercise 29eribulin 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Breast Neoplasms × Triptorelin Pamoate × 1 year × Clear all
NCT05982093 2026-04-24

SOLTI-2104

SOLTI Breast Cancer Research Group

Phase 2 Recruiting
96 enrolled
Breast

Breast Neoplasms

NCT05896566 2026-02-24

PREcoopERA

ETOP IBCSG Partners Foundation

Phase 2 Completed
231 enrolled
Breast

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

ETOP IBCSG Partners Foundation

Phase 3 Completed
3,066 enrolled 15 charts
Breast

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

ETOP IBCSG Partners Foundation

Phase 3 Completed
2,672 enrolled 14 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡